Westside Investment Management, Inc. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.

Quarter-by-quarter ownership
Westside Investment Management, Inc. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$1,0000.0%350.0%0.00%
Q1 2022$1,0000.0%350.0%0.00%
Q4 2021$1,0000.0%350.0%0.00%
Q3 2021$1,0000.0%350.0%0.00%
Q2 2021$1,0000.0%350.0%0.00%
Q1 2021$1,0000.0%350.0%0.00%
Q4 2020$1,0000.0%350.0%0.00%
Q3 2020$1,000
-90.0%
35
-86.5%
0.00%
Q2 2020$10,000
+11.1%
2600.0%0.00%
Q1 2020$9,000
-82.0%
260
-79.4%
0.00%
Q2 2019$50,000
-99.9%
1,2600.0%0.00%
-100.0%
Q4 2018$48,144,000
-4.6%
1,2600.0%0.02%
+12.5%
Q3 2018$50,462,000
-0.2%
1,2600.0%0.02%
-11.1%
Q2 2018$50,551,000
+3.3%
1,2600.0%0.02%
-33.3%
Q1 2018$48,950,000
+0.8%
1,260
-3.0%
0.03%
+3.8%
Q4 2017$48,582,000
-5.0%
1,299
+3.1%
0.03%
-16.1%
Q3 2017$51,156,000
-3.8%
1,2600.0%0.03%
-11.4%
Q2 2017$53,184,000
+0.7%
1,2600.0%0.04%
+40.0%
Q1 2017$52,832,000
-6.2%
1,260
-12.6%
0.02%
-34.2%
Q4 2016$56,310,0001,4420.04%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders